Regulatory news: Avalglucosidase alfa-ngpt (Nexviazyme) for late-onset Pompe disease-FDA approval summary.
作者信息
Punnoose Ann R, Jeng Linda J B, Maynard Janet W
机构信息
Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
出版信息
J Inherit Metab Dis. 2022 Nov;45(6):1015-1017. doi: 10.1002/jimd.12543. Epub 2022 Aug 18.
PMID:35929375
Abstract
摘要
Zotero 插件